Article
Interstitial lung disease and the STING pathway.
The Journal of clinical investigation - 1 Jun 2026
Velu Prasad Palani, Zhu Gaofeng, Mackenzie Karen J
Abstract excerpt
Identification of the genetic mutations underlying the ultrarare monogenic conditions STING-associated vasculopathy with onset in infancy (SAVI) and coatomer protein complex subunit alpha (COPA) syndrome revealed a role for the stimulator of interferon genes (STING) immune pathway in the pathogenesis of interstitial lung disease (ILD) in these conditions. STING-focused therapeutics could be a potential avenue for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
